Biopharma happenings, including deals and partnerships, and other news in brief: Adlai Nortye, Aosaikang, Halda, Harbour Biomed, J&J, Lannacheng.

Clinical updates, including data readouts and publications: Biohaven, Genmab, Mereo, Quralis, Ultragenyx.

Biopharmas raising money in public or private financings, including: Biomx, Indaptus, Tonix.

New hires and promotions in the med-tech industry, including: Beyond Air, Neogenomics.

Med-tech firms raising money in public or private financings, including: Glucotrack, Pathocare.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Capsovision, Vicarious Surgical.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Huonslab, Incyte Biosciences, Kalvista, Regeneraon, Samsung Bioepis, SN Bioscience, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Immutep, Foresee Pharmaceuticals.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Bioeq, JCR Pharmaceuticals, Ipsen, Italfarmaco, Simcere Zaiming, Zydus.

The top 10 med-tech stock gainers and losers for the week.